Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000723478 | SCV000331133 | uncertain significance | not provided | 2016-12-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000340120 | SCV000577187 | uncertain significance | not specified | 2017-04-07 | criteria provided, single submitter | clinical testing | The T572N variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The T572N variant is observed in 42/9798 (0.43%) alleles from individuals of African background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. However, this substitution occurs at a position that is conserved across species, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. |
Fulgent Genetics, |
RCV000765103 | SCV000896323 | uncertain significance | Eichsfeld type congenital muscular dystrophy; Congenital myopathy with fiber type disproportion | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001083468 | SCV001019394 | likely benign | Eichsfeld type congenital muscular dystrophy | 2024-01-13 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV000723478 | SCV002541953 | uncertain significance | not provided | 2021-08-16 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003920033 | SCV004735063 | likely benign | SELENON-related disorder | 2023-06-06 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Ce |
RCV000723478 | SCV005042291 | likely benign | not provided | 2024-04-01 | criteria provided, single submitter | clinical testing | SELENON: BS1 |